{"id":"W4402327339","doi":"10.1053/j.gastro.2024.08.036","title":"A Head-to-Head Comparison of Risankizumab and Ustekinumab as Second-Line Therapy in Moderate to Severely Active Crohn’s Disease","year":2024,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Ustekinumab; Medicine; Crohn's disease; Second-line therapy; Crohn disease; First line therapy; Head (geology); Internal medicine; Disease; Chemotherapy; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002200509,0.001168151,0.004768725,0.0006227033,0.0004417691,0.001541059,0.0008954782,0.001783362,0.006501833],"category_scores_gemma":[0.002287637,0.0005877108,0.003680217,0.0005503905,0.001068476,0.001423336,0.0006103488,0.003248109,0.000934886],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001138711,"about_ca_system_score_gemma":0.0009476822,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001600836,"about_ca_topic_score_gemma":0.004520872,"domain_scores_codex":[0.9984196,0.0008648799,0.0001299074,0.0001984133,0.0001095387,0.0002777328],"domain_scores_gemma":[0.9979529,0.000881562,0.0002948164,0.0001493037,0.0001237538,0.0005976107],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9783093,0.002056645,0.0006559969,0.0004044092,0.002244967,0.00003771868,0.00003749089,0.0002251733,0.001116227,0.00006845152,0.0002904212,0.01455311],"study_design_scores_gemma":[0.556503,0.4106296,0.01887419,0.0002017725,0.008560995,0.000177409,0.0002693405,0.0006734472,0.001242913,0.0004187172,0.002367806,0.00008081879],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9713964,0.02207911,0.0002996366,0.0006668211,0.001118226,0.000356537,0.0008654901,0.00004881339,0.003168861],"genre_scores_gemma":[0.9917024,0.004826506,0.0002539378,0.0006209338,0.0006221117,0.0001226043,0.0004651147,0.00001281335,0.001373762],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006501833,"threshold_uncertainty_score":0.02175075,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01555503337684474,"score_gpt":0.306295043607492,"score_spread":0.2907400102306473,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}